Amongst these genes, we prioritized the SOD2 gene as it has been reported to correlate with prostate cancer risk [28,29,30] and prognostic Gleason scores [26,27] [Supplementary Figure S3]. This evidence concerns the gene SOD2 and prostate carcinoma.